2011 年美国临床肿瘤学会临床实践指南关于 IV 期非小细胞肺癌化疗更新的 2009 年重点更新。
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
机构信息
Memorial Sloan-Kettering Cancer Center, New York, NY; American Society of Clinical Oncology, Alexandria, VA; and National Cancer Institute, Bethesda, MD.
出版信息
J Oncol Pract. 2012 Jan;8(1):63-6. doi: 10.1200/JOP.2011.000374. Epub 2011 Nov 29.
Abstract
ASCO produced the 2011 Focused Update based on phase III randomized clinical trials published on maintenance chemotherapy, addressing one question from the 2009 Guideline Update on chemotherapy for stage IV NSCLC: what is the optimal duration of first-line chemotherapy for stage IV NSCLC?
摘要
ASCO 基于维持化疗的 III 期随机临床试验发布了 2011 年重点更新，针对 2009 年 IV 期 NSCLC 化疗指南更新中的一个问题：IV 期 NSCLC 的一线化疗最佳持续时间是多久？
相似文献
1
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.2011 年美国临床肿瘤学会临床实践指南关于 IV 期非小细胞肺癌化疗更新的 2009 年重点更新。
J Oncol Pract. 2012 Jan;8(1):63-6. doi: 10.1200/JOP.2011.000374. Epub 2011 Nov 29.
2
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.IV 期非小细胞肺癌的系统治疗：美国临床肿瘤学会临床实践指南更新。
J Clin Oncol. 2017 Oct 20;35(30):3484-3515. doi: 10.1200/JCO.2017.74.6065. Epub 2017 Aug 14.
3
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.有驱动基因改变的 IV 期非小细胞肺癌的治疗：ASCO 和 OH（CCO）联合指南更新。
J Clin Oncol. 2021 Mar 20;39(9):1040-1091. doi: 10.1200/JCO.20.03570. Epub 2021 Feb 16.
4
Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.局部晚期非小细胞肺癌的根治性和辅助放疗：美国临床肿瘤学会临床实践指南对美国放射肿瘤学会循证临床实践指南的认可。
J Clin Oncol. 2015 Jun 20;33(18):2100-5. doi: 10.1200/JCO.2014.59.2360. Epub 2015 May 5.
5
Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline.非小细胞肺癌的姑息性胸部放射治疗：美国放射肿瘤学会（ASTRO）循证指南的 2018 年更新。
Pract Radiat Oncol. 2018 Jul-Aug;8(4):245-250. doi: 10.1016/j.prro.2018.02.009. Epub 2018 Apr 4.
6
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.Ⅰ期至ⅢA 期完全切除的非小细胞肺癌的辅助全身治疗和辅助放疗：美国临床肿瘤学会/安大略癌症护理临床实践指南更新。
J Clin Oncol. 2017 Sep 1;35(25):2960-2974. doi: 10.1200/JCO.2017.72.4401. Epub 2017 Apr 24.
7
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.美国临床肿瘤学会临床实践指南更新：关于 IV 期非小细胞肺癌的化疗。
J Oncol Pract. 2010 Jan;6(1):39-43. doi: 10.1200/JOP.091065.
8
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.无驱动基因改变的 IV 期非小细胞肺癌的治疗：ASCO 和 OH（CCO）联合指南更新。
J Clin Oncol. 2020 May 10;38(14):1608-1632. doi: 10.1200/JCO.19.03022. Epub 2020 Jan 28.
9
Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.不可切除的非小细胞肺癌治疗临床实践指南。1997年5月16日由美国临床肿瘤学会采用。
J Clin Oncol. 1997 Aug;15(8):2996-3018. doi: 10.1200/JCO.1997.15.8.2996.
10
Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.立体定向体部放疗治疗早期非小细胞肺癌：美国临床肿瘤学会对美国放射肿瘤学会循证指南的认可。
J Clin Oncol. 2018 Mar 1;36(7):710-719. doi: 10.1200/JCO.2017.74.9671. Epub 2017 Nov 6.
引用本文的文献
1
Docetaxel Plus Nedaplatin or Carboplatin as Second-Line Chemotherapy for Advanced Lung Squamous Cell Carcinoma in Real-World Practice: A Single-Center Experience.多西他赛联合奈达铂或卡铂作为晚期肺鳞癌二线化疗的真实世界实践：一项单中心经验。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231206334. doi: 10.1177/15330338231206334.
2
Radiochemotherapy-induced DNA repair promotes the biogenesis of gastric cancer stem cells.放化疗诱导的 DNA 修复促进胃癌干细胞的发生。
Stem Cell Res Ther. 2022 Sep 24;13(1):481. doi: 10.1186/s13287-022-03165-8.
3
Prognostic Model to Predict Overall Survival for Metastatic Non-Small Cell Lung Cancer Patients Treated With Chemotherapy Combined With Concurrent Radiation Therapy to the Primary Tumor: Analysis From Two Prospective Studies.预测接受化疗联合原发肿瘤同步放疗的转移性非小细胞肺癌患者总生存期的预后模型：两项前瞻性研究的分析
Front Oncol. 2021 Feb 25;11:625688. doi: 10.3389/fonc.2021.625688. eCollection 2021.
4
Clinical observation of Pemetrexed first-line treatment in advanced non-squamous lung cancer or non-small cell lung cancer without driver-mutations: a phase 2, single-arm trial.培美曲塞一线治疗晚期非鳞状非小细胞肺癌或无驱动基因突变的非小细胞肺癌的临床观察：一项2期单臂试验。
Ann Transl Med. 2020 Oct;8(20):1315. doi: 10.21037/atm-20-6539.
5
Harnessing Clinical Sequencing Data for Survival Stratification of Patients with Metastatic Lung Adenocarcinomas.利用临床测序数据对转移性肺腺癌患者进行生存分层
JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00307. Epub 2019 Mar 28.
6
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing.非小细胞肺癌的生物标志物：印度分子检测共识指南。
Adv Ther. 2019 Apr;36(4):766-785. doi: 10.1007/s12325-019-00903-y. Epub 2019 Mar 12.
7
Effect of pemetrexed on brain metastases from nonsmall cell lung cancer with wild-type and unknown EGFR status.培美曲塞对野生型及表皮生长因子受体（EGFR）状态未知的非小细胞肺癌脑转移瘤的影响。
Medicine (Baltimore). 2019 Jan;98(3):e14110. doi: 10.1097/MD.0000000000014110.
8
Establishment of a prospective multicenter cohort for advanced non-small cell lung cancer in China (CAPTRA-Lung study).中国晚期非小细胞肺癌前瞻性多中心队列研究（CAPTRA-Lung 研究）。
Thorac Cancer. 2018 Dec;9(12):1795-1800. doi: 10.1111/1759-7714.12865. Epub 2018 Sep 27.
9
In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma.载内皮抑素壳聚糖纳米粒联合紫杉醇对Lewis肺癌的体内抗肿瘤作用
Drug Deliv. 2017 Nov;24(1):1410-1418. doi: 10.1080/10717544.2017.1378938.
10
Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status.来自胸腔积液的肺腺癌细胞中低水平的核纤层蛋白A表达是一个与转移部位数量多和体能状态差相关的不良因素。
PLoS One. 2017 Aug 14;12(8):e0183136. doi: 10.1371/journal.pone.0183136. eCollection 2017.
本文引用的文献
1
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.2011 年美国临床肿瘤学会临床实践指南关于 IV 期非小细胞肺癌化疗更新的 2009 年重点更新。
J Clin Oncol. 2011 Oct 1;29(28):3825-31. doi: 10.1200/JCO.2010.34.2774. Epub 2011 Sep 6.
2
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.美国临床肿瘤学会临床实践指南更新：关于 IV 期非小细胞肺癌的化疗。
J Clin Oncol. 2009 Dec 20;27(36):6251-66. doi: 10.1200/JCO.2009.23.5622. Epub 2009 Nov 16.
Zotero 插件